HomeNewsScience and TechnologyFavipiravir launched by Hetero group for treatment of Covid-19 patients

Favipiravir launched by Hetero group for treatment of Covid-19 patients

Contents

Favipiravir launched by Hetero group

  • The Hetero group has made the launching of Favipiravir in India. The Drug Controller General of India (DCGI) has given clearance to the company to sell the product in the market. Favipiravir drug comes under brand drug ‘Favivir’ that is useful for the treatment of mild to moderate COVID-19 patients.

Important points about Favivir Drug –

  • Favivir Drug is helpful in the treatment of a significant amount of the COVID-19 patient. mainly for mild to moderate symptoms.
  • One tablet price of generic favipiravir drug is 59 rupees. Hetero Healthcare is working on the distribution of drug.
  • USFDA and the EU have provided their clearances to Favivir Drug. The Favivir drug is 2nd which is developed by Hetero. prior to this, Company introduced Covifor, the generic version of Remdesivir injection.

Favipiravir launched by Hetero group

Stay Connected With Facebook Page

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Advertisement

Latest Articles